
March 15, 2025
Joshua Zeidner, MD, Publishes “ENHANCE-2 Study” on Magrolimab and Azacitidine for TP53-Mutated AML.
Joshua Zeidner, MD Joshua Zeidner, MD, an Associate Professor of Medicine and Chief of Leukemia Research, published a paper in the journal Blood. Titled “Magrolimab plus azacitidine vs physician’s choice…